VeraBIND Tau assay | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,713 results for “VeraBIND Tau assay”

Trials

View all 3929 →

Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins

115 participants · First posted Jul 1, 2024

Tau/P-Tau and Neurocognitive Outcomes in Children

20 participants · First posted Apr 30, 2018

Tau PET/CT in Various Tau-Related Disease Patients

500 participants · First posted Nov 15, 2024

Drugs

View all 543 →

11C-TAU-7

TAU-2023

Investigational

Interferon tau

Organizations

View all 61 →

Alpha Tau Medical

Israel

Sigma Tau I.f.r S.p.a.

SIGMA-TAU RESEARCH INC

United States

News

View all 1180 →

VeraBIND Tau Assay Shows Superior Early Detection Capabilities for Alzheimer's Disease in AAIC 2025 Studies

Nautilus Biotechnology Launches Early Access Program for Single-Molecule Proteomics Platform with Tau Proteoforms Assay

Spear Bio to Unveil First Commercially Available Singleplex eMTBR-Tau Immunoassay and Novel pTau 217 Assay at AAIC 2026

Page 1 of 572